Gyre Therapeutics, Inc.

GYRE·NasdaqCM·Healthcare
Compare
4.44000.0000 (0.00%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close4.4400
Open4.5700
Day range4.33004.6500
52-week range4.27009.1400
Off day high−4.52%
Off 52-week high−51.42%
Volume256.35K
Avg. volume (3M)136.59K
Market cap470.79M
EPS (TTM)-0.2500
Forward P/E74.00
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)4.92
Shares outstanding106.03M
Short interest6.48% of float
Earnings dateAug 7, 2026 (est.)
Analyst target18.6667
Profit margin−19.33%

Against its peers

Compare in full ›
GYRE GPCR GNFT.PA VCRE IVA ANNX
Market cap 470.79M 1.45B 574.36M 265.87M 914.17M 820.88M
P/E (TTM) — — — — — —
Forward P/E 74.0 -9.6 63.8 — -5.2 -4.0
Price/book 4.4 1.1 -11.8 — 13.8 4.1
Dividend yield — — — — — —
1-year change −39.92% −39.17% +218.29% −41.91% −7.42% +43.38%
Today 0.00% +0.05% +3.04% +1.18% −3.97% +3.34%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All GYRE news ›

From the 4Search news index, newest first.

In the news

2mentions in 30 days
2with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance